free web tracker
93

Official E-Rezept App iOS Source Code by gematik

The gematik E-Rezept App for iOS is the official open-source application enabling users to receive and redeem electronic prescriptions (e-prescriptions)…

The gematik E-Rezept App for iOS is the official open-source application enabling users to receive and redeem electronic prescriptions (e-prescriptions) digitally. Launched on July 1, 2021, this app facilitates a seamless transition from traditional paper prescriptions to a secure, digital format for individuals with public health insurance in Germany.

Developed using Swift and SwiftUI, the app leverages Apple’s Combine framework for efficient operation scheduling. Its architecture is modular, utilizing The Composable Architecture to ensure scalability and maintainability. The Xcode project is generated using xcodegen, with complex build configurations managed through Fastlane. The application requires macOS 11 and iOS 14.0 or later.

To begin development, clone the repository and execute make setup to install dependencies and generate the Xcode project. The app interacts with the telematics infrastructure, managed by gematik, to securely store e-prescriptions. Authentication is facilitated through the user’s public health insurance card.

The source code is licensed under the European Union Public Licence (EUPL) 1.2, promoting transparency and collaboration within the developer community. While contributions are not currently open, gematik plans to enable community involvement in future iterations.

This repository serves as a valuable resource for developers interested in healthcare applications, offering insights into integrating secure authentication, managing sensitive health data, and adhering to regulatory standards. By studying this project, developers can gain a comprehensive understanding of building compliant and user-friendly health applications.

rysasahrial

A lecturer specializing in mobile application development using the Java programming language. Actively engaged in teaching, research, and mobile technology development.

Leave a Reply

Your email address will not be published. Required fields are marked *